Category:Malignant solid neoplasm, EGFR-mutated medications

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 16:26, 21 September 2023 by Jwarner (talk | contribs) (Jwarner moved page Category:Solid malignant neoplasm, EGFR-mutated medications to Category:Malignant solid neoplasm, EGFR-mutated medications)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Medications with some degree of efficacy in the treatment of EGFR-mutated tumors, regardless of anatomic site of origin.

Pages in category "Malignant solid neoplasm, EGFR-mutated medications"

This category contains only the following page.

E

Erlotinib (Tarceva)

Retrieved from "https://hemonc.org/w/index.php?title=Category:Malignant_solid_neoplasm,_EGFR-mutated_medications&oldid=77889"

Site-agnostic medications